Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections.

Winstanley C, O'Brien S, Brockhurst MA. · 2016

Read Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections. by Winstanley C, O'Brien S, Brockhurst MA. (2016) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc4854172.txt.

Introduction

Craig Winstanley, Siobhan O'Brien, and Michael A. Brockhurst reviewed in Trends in Microbiology in 2016 how Pseudomonas aeruginosa evolves inside cystic fibrosis lungs. This bacterium settles for years in the thick lung mucus of cystic fibrosis. Over time it sheds attack traits, shifts to a slime-bound biofilm life, and gains strong drug resistance.

Within one patient, the population splits into many forms that differ in drug response and toxin output, and the mix keeps changing. Gene studies show deep diversity, even rival lineages caught from other patients living side by side. That moving diversity makes lab tests and treatment choices hard, and the review maps how it arises.

Catalog record

CREATORWinstanley C, O'Brien S, Brockhurst MA.
YEAR2016
COLLECTIONPAPERS
FORMATTXT
FILE SIZE45 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC4854172

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Pseudomonas aeruginosa Evolutionary Adaptation and Diversification in Cystic Fibrosis Chronic Lung Infections By Craig Winstanley, Siobhan O’Brien, Michael A Brockhurst Published in: Trends in Microbiology DOI: 10.1016/j.tim.2016.01.008 ABSTRACT Abstract Pseudomonas aeruginosa populations undergo a characteristic evolutionary adaptation during chronic infection of the cystic fibrosis (CF) lung, including reduced production of virulence factors, transition to a biofilm-associated lifestyle, and evolution of high-level antibiotic resistance. Populations of P. aeruginosa in chronic CF lung infections typically exhibit high phenotypic diversity, including for clinically important traits such as antibiotic resistance and toxin production, and this diversity is dynamic over time, making accurate diagnosis and treatment challenging. Population genomics studies reveal extensive genetic diversity within patients, including for transmissible strains the coexistence of highly divergent lineages acquired by patient-to-patient transmission. The inherent spatial structure and spatial heterogeneity of selection in the CF lung appears to play a key role in driving P. aeruginosa diversification. Keywords: Pseudomonas aeruginosa, cystic fibrosis, evolution, adaptation, population biology PSEUDOMONAS AERUGINOSA INFECTION IN CYSTIC FIBROSIS Cystic fibrosis (CF; see Glossary) is a debilitating, genetically inherited disease characterised by defects in a transport protein (the cystic fibrosis transmembrane regulator), resulting in sticky mucus, most notably in the respiratory tract [1]. CF patients are susceptible to chronic lung infections, the predominant cause of the morbidity and mortality associated with the disease. The most common pathogen in this respect is Pseudomonas aeruginosa, a highly versatile bacterium capable of causing a wide range of mostly opportunistic infections, as well as occupying a variety of environmental niches [2]. The ecological flexibility of P. aeruginosa can be attributed to its large genome (typically >6 Mb), which contains a particularly high proportion of regulatory genes, as well as a large number of genes involved in the catabolism, transport, and efflux of organic compounds 3, 4. In CF, there has been some progress with development of aggressive early eradication therapies, whereby treatment is initiated as soon as the pathogen is detected, which delays the onset of chronic infection [5]. However, once a chronic infection is established by P. aeruginosa, it is apparently impossible to eradicate. During the course of chronic infection, CF patients produce samples (most commonly sputum) that are subjected to microbiological analysis for diagnostic purposes (identification of pathogens and antimicrobial susceptibility testing) and have proven to be a rich resource for researchers interested in analyses of the evolution of bacteria during chronic infection. As a discipline, microbiology has depended heavily on analysis of cultured organisms [6], and microbiologists are ingrained with the importance of obtaining single pure colonies. Hence, the study of bacterial pathogens during infection, including chronic CF infections, has relied heavily upon an assumption that bacterial populations at any given time are genetically uniform, at least at the level of ‘strains’, and that therefore it is justifiable to study and diagnose infections on the basis of single isolates. As a result, for many years researchers have assumed that it is possible to draw conclusions about the whole infecting bacterial population from the traits of single bacterial colonies. It is, however, increasingly clear that this assumption may not always be true. In this review we discuss the phenotypic and genomic studies that have advanced our understanding of the adaptation and evolution of P. aeruginosa populations during chronic infections in the CF lung, highlighting the evidence demonstrating that infecting P. aeruginosa populations are highly diverse both genetically and phenotypically. We further discuss the causes and consequences of this diversity with respect to the underlying evolutionary processes and the clinical implications. P. AERUGINOSA PHENOTYPIC ADAPTATIONS COMMONLY ASSOCIATED WITH CF INFECTIONS The CF lung is a heterogeneous, hostile, and stressful environment for invading bacteria, and P. aeruginosa populations must overcome these challenges to persist and survive. Postulated stressors in the CF lung include osmotic stress [7] due to the viscous mucus, oxidative [8] and nitrosative [9] stresses due to host responses, sublethal concentrations of antibiotics [10], and the presence of other microorganisms 11, 12. It has been recognised for many years that P. aeruginosa undergoes evolutionary changes in response to these selective forces during the chronic infection process. Phenotypic analysis of isolates show the emergence of mucoid colonies [13], caused by overproduction of the polysaccharide alginate, which is widely considered to be a marker for the transition to chronic infection. Alginate is one of three exopolysaccharides (along with Pel and Psl) that play important roles in the development and structural maintenance of a biofilm matrix that can offer P. aeruginosa protection from antibiotics and host responses [14]. Other adaptations include the accumulation of auxotrophic mutations in the amino acid-rich lung environment [15], loss of motility [16], and the emergence of hypermutators [17], which display elevated mutation rates due to defects in DNA repair mechanisms. Given that CF patients are subjected to prolonged and often intensive therapy with antibiotics [18], the evolution of antibiotic resistances is also a common adaptation [19]. A recurring theme in the phenotypic analysis of CF isolates is the tendency for P. aeruginosa to become defective in terms of some of its key virulence factors (Box 1), such as type III secretion and the quorum sensing (QS) system (Figure 1). In CF, the accumulation of mutations in the gene encoding the key QS regulator, LasR, causing loss of QS regulation, is especially common [20]. Other mutations often found associated with CF isolates of P. aeruginosa include mutations in gacS and retS, genes implicated in the switch between acute and chronic virulence (Box 1, Figure 1). Other regulators, such as AmpR [21], have also been implicated in this switch to chronicity, and it seems likely that a number of global regulatory systems may actually be involved. The accumulation of virulence factor mutations has been interpreted as P. aeruginosa adapting to lose its acute virulence during chronic infections [22]. However, it is clear that many virulence factors (for example, QS-regulated factors and QS signal molecules) can still be detected in patient sputum samples during chronic infections [23]. Box 1Pseudomonas aeruginosa Virulence FactorsP. aeruginosa virulence has largely been defined in terms of acute infections, for which models are readily available and loss of function mutations can be easily demonstrated 71, 72, 73. The expression of virulence genes in P. aeruginosa is controlled by extremely complex, interweaving regulatory circuits [35] and multiple signalling systems [74]. For an opportunistic pathogen, P. aeruginosa produces an impressive array of particularly secreted virulence factors, utilising its type III secretion system to secrete various exotoxins (ExoS, ExoU, ExoT, and ExoY) [75], and quorum sensing (QS) systems (cell-density-dependent regulation) to control numerous important secreted virulence factors 23, 76, including secreted pyocyanin, elastase, cyanide, and rhamnolipid. The secretion of toxins, coupled with phenotypes such as motility (swimming, swarming, and twitching), is considered to be important for acute infections. In contrast, apart from biofilm formation, virulence factors that are important in chronic infections are less well understood. It has been proposed that the GAC system network (incorporating the two-component regulatory system GacA/GacS, two other sensor kinases RetS/LadS, the small regulatory protein RsmA and the small RNAs RsmZ/RsmY) controls the reversible transition from acute to chronic infections [74]. This is based on a switch between acute virulence factors (swarming motility, lipase, rhamnolipids and type III secretion) and chronic virulence

Read the complete text